Uma Prabhakar
Impact in
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery
- Immunology top 5%
- Immunotherapy and Immune Responses
Papers in
- Oncology 16
- Cytokine Signaling Pathways and Interactions 5
- Cancer Immunotherapy and Biomarkers 5
- Immunology 12
- T-cell and B-cell Immunology 5
- Immunotherapy and Immune Responses 4
- Co-authors
- Hugh M. Davis (9 shared papers)Alberto Gabizón (2 shared papers)William C. Zamboni (2 shared papers)Piotr Grodzinski (3 shared papers)Eva M. Sevick‐Muraca (1 shared paper)David C. Blakey (1 shared paper)Simon T. Barry (1 shared paper)Omid C. Farokhzad (1 shared paper)
- Journals
- Journal of Clinical Oncology (6 papers)Cellular Immunology (3 papers)Journal of Immunological Methods (3 papers)Inflammation Research (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesUnited KingdomJapan
In The Last Decade
Uma Prabhakar
40 papers receiving 3.0k citations
Uma Prabhakar's Hit Papers
Peers
Comparison fields: 5 of 126
- Biomaterials 748
- Immunology 806
- Oncology 645
- Biomedical Engineering 810
- Immunology and Allergy 106
Countries citing papers authored by Uma Prabhakar
This map shows the geographic impact of Uma Prabhakar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Uma Prabhakar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Uma Prabhakar more than expected).
Fields of papers citing papers by Uma Prabhakar
This network shows the impact of papers produced by Uma Prabhakar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Uma Prabhakar. The network helps show where Uma Prabhakar may publish in the future.
Co-authors
The 25 scholars most cited alongside Uma Prabhakar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Challenges and Key Considerations of the Enhanced Permeability and Retention Effect for Nanomedicine Drug Delivery in Oncology Hit paper breakdown → | 2013 | 1197 |
| 2 | 2004 | 221 | |
| 3 | 2002 | 162 | |
| 4 | 2010 | 152 | |
| 5 | 2008 | 140 | |
| 6 | 1994 | 122 | |
| 7 | A multicenter, phase II study of infliximab plus gemcitabine in pancreatic cancer cachexia. | 2008 | 122 |
| 8 | 1998 | 116 | |
| 9 | 2011 | 93 | |
| 10 | 1996 | 87 | |
| 11 | 2010 | 86 | |
| 12 | 2007 | 81 | |
| 13 | 2004 | 68 | |
| 14 | 2007 | 52 | |
| 15 | 2014 | 51 | |
| 16 | 2008 | 46 | |
| 17 | 2010 | 45 | |
| 18 | 1995 | 35 | |
| 19 | 1995 | 30 | |
| 20 | Protein kinase C regulates TNF-alpha production by human monocytes. | 1993 | 29 |
About Uma Prabhakar
Uma Prabhakar is a scholar working on Oncology, Immunology, Molecular Biology, Physiology and Pathology and Forensic Medicine, having authored 41 papers that have together received 3.1k indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (5 papers), T-cell and B-cell Immunology (5 papers), Cancer Immunotherapy and Biomarkers (5 papers), Lymphoma Diagnosis and Treatment (4 papers), Immunotherapy and Immune Responses (4 papers), Phosphodiesterase function and regulation (4 papers), Advanced Biosensing Techniques and Applications (4 papers) and Dermatology and Skin Diseases (3 papers). The work is most often cited by research in Biomaterials (748 citations), Immunology (806 citations), Oncology (645 citations), Biomedical Engineering (810 citations) and Immunology and Allergy (106 citations). Uma Prabhakar has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include Hugh M. Davis, Alberto Gabizón, William C. Zamboni, Piotr Grodzinski, Eva M. Sevick‐Muraca, David C. Blakey, Simon T. Barry, Omid C. Farokhzad, Rakesh K. Jain and Hiroshi Maeda. Their work appears in journals such as Journal of Clinical Oncology, Cellular Immunology, Journal of Immunological Methods, Inflammation Research and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.